Table 1.
Clinical parameter (n = data available) | All participants (SD, IQR or %) | Survivor day 40 (SD, IQR or %)n = 75 | Non-survivor day 40 (SD, IQR or %)n = 73 | Survival significance (univariate) | Odds ratio (95% CI) bacterial load data Model 1 |
Survival significance bacterial load model 1 n = 102 (multivariate) |
---|---|---|---|---|---|---|
Female gender n = 144 | 72 (51%) | 36 (48%) | 36 (49%) | 0.4c | 2.24 (0.62:8.03) |
0.21 |
Mean age n = 144 | 32.1 (SD 9.7) | 30 (SD 9.1) | 33 (SD 10.2) | 0.06a | 1.02 (0.95:1.09) |
0.54 |
HIV antibody positive n = 141 | 115 (82%) | 60 (80%) | 55 (75%) | 0.8c | 1.43 (0.25:8.2) |
0.68 |
Seizures n = 142 | 50 (35%) | 16 (21%) | 34 (47%) | 0.002c | 7.2 (2.18:23.8) |
0.001 |
Altered mental state GCS <15 | 111 (81%) | 49 (65%) | 61 (84%) | <0.001c | 4.55 (0.41:51.0) |
0.22 |
Median Glasgow coma score (GCS) n = 137 | 11 (8–14) | 13 (10–15) | 9 (7–11) | <0.001b | 0.72 (0.59:0.92) |
0.001 |
Dexamethasone n = 89 | 49/89 (55%) | 28 (57%) | 21 (43%) | 0.36c | 0.47 (0.12:1.87) |
0.28 |
Glycerol n = 62 | 27/62 (46%) | 8 (30%) | 19 (70%) | 0.03c | 2.29 (0.4:12.9) |
0.34 |
Mean Haemoglobin (g/dL) n = 129 | 11.3 (SD 2.9) | 11.3 (SD 2.4) | 11.4 (SD 3.2) | 0.94a | 0.82 (0.68:0.98) |
0.032 |
Median CSF white cell count (mm3/ml) n = 143 | 760 (181–2600) | 1120 (320–1320) | 370 (105–1480) | 0.021b | 1.0 (1.0–1.0) |
0.91 |
Median CSF bacterial load (DNA copies/ml) with IQR | ||||||
Admission n = 102 | 6.5 × 105 (1.08x105–2.96 × 106) | 8.10 × 105 (4.74 × 104–3.24 × 106) |
5.94 × 105 (1.59 × 105–2.42 × 106) |
0.52b | 1.0 (1.0–1.0) |
0.64 |
48 h post antibiotics n = 42 | 2.9 × 104 (3.8x103–2.12 × 105) | 2.72 × 104 (4.12 × 103–2.43 × 105) |
7.96 × 104 (1.56 × 103–2.19 × 105) |
0.64b | 1.0 (1.0–1.0) |
0.22 |
t-test.
Mann–Whitney-U test.
Fisher exact test/Chi-squared test.